MedTrace Logo

Ovarian Cancer and Immune Response to Flu Vaccine

NCT00478387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2016-10-05

No results posted yet for this study

Summary

The purpose of this study is to determine what the immune response is of ovarian cancer patients in remission, when they are given the flu vaccine. After receiving the flu vaccine, patients will have blood drawn 5 times in 12 months to study antibody response to the flu vaccine.

Conditions

Interventions

BIOLOGICAL

The current season's trivalent killed influenza vaccine

Sponsors & Collaborators

Principal Investigators

  • Christina S Chu, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00478387 on ClinicalTrials.gov